Trending Topic

11 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Lung cancer is the second most common type of cancer worldwide and in the USA, with its incidence varying depending on geographic and socioeconomic factors.1–3 According to data from the Global Cancer Observatory: Cancer Incidence, Mortality and Prevalence (GLOBACAN) database, an estimated 2.48 million new cases of lung cancer were reported in 2022.4,5 Although lung cancer rates in the […]

Chinthalapally V Rao, AACR 2018 – Aspirin & NSAIDs in Colorectal Cancer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 1st 2018

Chinthalapally V Rao from the University of Oklahoma Health Sciences Center, Oklahoma City, OK, US, talks to us about the protective role of aspirin and other NSAIDs in colorectal cancer.

1. What is currently known about the protective role of aspirin and other NSAIDs in colorectal cancer? (0:08)
2. Could you tell us a little about your recent study investigating intermittent dosing regimens of naproxen and aspirin in colon adenoma? (0:30)
3. How often and for how long should naproxen and aspirin be taken to achieve a protective effect? (1:18)
4. What are the limitations of this approach? (1:41)
5. What future studies are planned? (2:15)

Speaker disclosures: Chinthalapally V Rao has nothing to disclose in relation to this video interview.

Filmed at the American Association for Cancer Research (AACR) Annual Meeting 2018, Chicago, IL, US, April 14–18, 2018.

NSAIDS = non-steroidal anti-inflammatory drugs

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup